Default: European Journal of Heart Failure

ISSN: 1388-9842

Journal Home

Journal Guideline

European Journal of Heart Failure Q1 Unclaimed

Wiley-Blackwell United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

European Journal of Heart Failure is a journal indexed in SJR in Cardiology and Cardiovascular Medicine with an H index of 127. It has an SJR impact factor of 5,556 and it has a best quartile of Q1. It is published in English.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

- €

Gold OA

-

Green OA

- €

Non OA

Metrics

European Journal of Heart Failure

5,556

SJR Impact factor

127

H Index

288

Total Docs (Last Year)

808

Total Docs (3 years)

7524

Total Refs

5349

Total Cites (3 years)

437

Citable Docs (3 years)

10,72

Cites/Doc (2 years)

26,13

Ref/Doc


Best articles

A new model of congestive heart failure in the mouse due to chronic volume overload

View more

ACE inhibitors are better than AT1receptor blockers (ARBs)' - controversies in heart failure

View more

Ambulatory vasodilator therapy in heart failure: systematic review of the literature and personal observational experience

View more

Amlodipine reduces myocardial ischaemia during exercise without compromising left ventricular function in patients with silent ischaemia: a randomised, double-blind, placebo-controlled study

View more

Angiotensin converting enzyme (ACE) gene expression in the human left ventricle: effect of ACE gene insertion/deletion polymorphism and left ventricular function

View more

Angiotensin II antagonists are superior to ACE inhibitors; David vs. Goliath

View more

Angiotensin-II type 1 receptor gene polymorphism and long-term survival in patients with idiopathic congestive heart failure

View more

Beta-adrenergic receptor blockade and the angiotensin-converting enzyme deletion polymorphism in patients with chronic heart failure

View more

Beta-blockers for advanced heart failure - how far can you go?

View more

Can natriuretic peptides be used for the diagnosis of diastolic heart failure?

View more

Cardiac peptides and plasma renin activity in acute dilated cardiomyopathy

View more

Catecholamine levels in heart failure due to dilated cardiomyopathy and their relationship to the severity of heart failure

View more
SHOW MORE ARTICLES

Chronic infusion of dobutamine and nitroprusside in patients with end-stage heart failure awaiting heart transplantation: safety and clinical outcome

View more

Circulating matrix metalloproteinase-2 is elevated in patients with congestive heart failure

View more

Clinical depression is common and significantly associated with reduced survival in patients with non-ischaemic heart failure

View more

Clinical profile and management of heart failure: rural community hospital vs. metropolitan heart center

View more

Comparison of different methods of functional evaluation in patients with chronic heart failure

View more

Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience

View more

Comprehensive local muscle training increases aerobic working capacity and quality of life and decreases neurohormonal activation in patients with chronic heart failure

View more

Dantrolene sodium improves the force-frequency relationship and beta-adrenergic responsiveness in failing human myocardium

View more

Depression increasingly predicts mortality in the course of congestive heart failure

View more

Diagnosis of heart failure in elderly patients in primary care

View more

Do we have reasons to be enthusiastic about pacing to treat advanced heart failure?

View more

Does in-patient ECG monitoring have an impact on medical care in chronic heart failure patients?

View more

Comments

No comments ... Be the first to comment!